Abstract:Esophageal cancer is one of the most common types of malignant tumors located within the digestive system, with >50% of esophageal cancer cases worldwide occurring in China. Recent studies have demonstrated that long non-coding RNAs (lncRNAs) are frequently dysregulated in cancer; however, few lncRNAs have been characterized in esophageal squamous cell carcinoma (ESCC). In the present study, a novel lncRNA, SET-binding factor 2 (SBF2) antisense RNA1 (SBF2-AS1) was exhibited in ESCC. Expression levels of SBF2-AS1 in ESCC and adjacent non-cancerous tissues were detected using the reverse transcription-quantitative polymerase chain reaction. SBF2-AS1 was knocked down, and proliferation, migration, invasion, apoptosis and the cell cycle were examined in ESCC cells. Results identified that SBF2-AS1 was significantly upregulated in ESCC compared with adjacent non-cancerous tissues (fold increase, 8.82; P=0.023). The SBF2-AS1 expression level was significantly increased in patients who had a smoking (9.927 vs. 4.507; P=0.030) and/or drinking (10.938 vs. 4.232; P=0.032) history. Patients with a large tumor size exhibited increased SBF2-AS1 expression (≥4 vs. <4 cm, 14.898 vs. 5.435; P=0.018). Patients with advanced ESCC exhibited increased upregulation of SBF2-AS1 [tumor-node-metastasis (TNM) I-II vs. TNM III-IV, 1.302 vs. 15.475; P<0.01]. SBF2-AS1 was also silenced using small interfering RNA. Cell proliferative and invasive ability were significantly inhibited (P<0.05) following SBF2-AS1 silencing, the cell cycle was arrested in the G2 phase; however, there was no significant difference in the proportion of apoptotic cells. Gene Set Enrichment Analysis revealed that genes associated with cell cycle biological processes, including the cancer suppressor gene cyclin-dependent kinase 1A (CDKN1A), were significantly associated with SBF2-AS1 in ESCC tissues. Further validation confirmed that CDKN1A expression levels were increased in ECA-109 cells following SBF2-AS1 silencing. The results of the present study demonstrate that SBF2-AS1 is significantly upregulated in ESCC, and that silencing of SBF2-AS1 inhibits the proliferative and invasive ability of ESCC cells. SBF2-AS1 may be a novel biomarker and therefore a potential therapeutic target for ESCC.

E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.

E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AF1 Promotes Non-Small-Cell Lung Cancer Metastasis through Regulating miR-362-3p/GRB2 Axis

High Expression of Long Non-Coding RNA SBF2-AS1 Promotes Proliferation in Non-Small Cell Lung Cancer.

The molecular mechanisms of the long noncoding RNA SBF2-AS1 in regulating the proliferation of oesophageal squamous cell carcinoma

Long Noncoding RNASBF2-AS1 Promotes Gastric Cancer Progression Via Regulating Mir-545/Ems1 Axis

LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis

Long noncoding RNA CASC15 is upregulated in non-small cell lung cancer and facilitates cell proliferation and metastasis via targeting miR-130b-3p.

LncRNA SBF2-AS1 Inhibits Apoptosis and Promotes Proliferation in Lung Cancer Cell Via Regulating FOXM1.

Long Noncoding RNA SBF2-AS1 is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma

Upregulated long non-coding RNA SBF2-AS1 promotes proliferation in esophageal squamous cell carcinoma.

LncRNA SBF2-AS1: A Budding Star in Various Cancers

RETRACTED ARTICLE: Silencing of Long Noncoding RNA SBF2-AS1 Inhibits Proliferation, Migration and Invasion and Contributes to Apoptosis in Osteosarcoma Cells by Upregulating Microrna-30A to Suppress FOXA1 Expression

Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1

LINC00461/miR-4478/E2F1 Feedback Loop Promotes Non-Small Cell Lung Cancer Cell Proliferation and Migration.

SP1-upregulated LBX2-AS1 promotes the progression of glioma by targeting the miR-491-5p/LIF axis

YY1-induced lncRNA ZFPM2-AS1 facilitates cell proliferation and invasion in small cell lung cancer via upregulating of TRAF4

Novel Long Non-Coding RNA LBX2-AS1 Indicates Poor Prognosis and Promotes Cell Proliferation and Metastasis Through Notch Signaling in Non-Small Cell Lung Cancer.

LncRNA NR2F2-AS1 Promotes Tumourigenesis Through Modulating BMI1 Expression by Targeting Mir-320B in Non-Small Cell Lung Cancer

LncRNA SBF2 Antisense RNA 1 Accelerates the Progression of Colon Cancer Via PI3K/Akt/mTOR Signaling Pathway by Targeting Mir-506-3p/zeb1 Axis

Forkhead box L2 is a target of miR‐133b and plays an important role in the pathogenesis of non‐small cell lung cancer

Expression and Clinical Significance of Long Non-Coding RNA SBF2-AS1 in Non-Small Cell Lung Cancer